Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

POLATUZUMAB VEDOTIN-PIIQ

FDA · BLA · 2026-03-18

AgencyFDA
Submission typeBLA
Action date2026-03-18
BrandPOLIVY
SponsorGENENTECH
RouteINTRAVENOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:31:07.575Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:POLATUZUMAB VEDOTIN-PIIQ:2026-03-18

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

POLATUZUMAB VEDOTIN-PIIQ — approval | AEaH